Active immunotherapy against cancer: present status.
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D001500:BCG Vaccine / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000628:therapy; D006168:Guinea Pigs; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012004:Rectal Neoplasms / Q000628:therapy; D014611:Vaccination
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D006649:Histocompatibility Antigens; C029237:tumor-associated transplantation antigen